Page 33 - Managed Care News Today

/PRNewswire/ -- When common medical procedures were performed in a hospital outpatient department (HOPD) rather than a doctors office, costs were...

In August 2023, the U.S. District Court for the District of Arizona joined "the growing number of courts that have concluded" that judicial approval of Fair Labor Standards Act (FLSA)...

Rockefeller Capital Management L.P. lifted its position in Centene Co. (NYSE:CNC – Free Report) by 12.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 1,240,754 shares of the company’s stock after purchasing an additional 133,179 shares during the quarter. Rockefeller Capital Management L.P. owned […]

Prescription drug costs have skyrocketed and become a growing financial burden, but the White House’s drug price controls will not solve the drug affordability crisis. However, they will threaten the development of future cures and harm patient health.

Gotham Asset Management LLC lifted its stake in shares of Centene Co. (NYSE:CNC – Free Report) by 109.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 172,099 shares of the company’s stock after buying an additional 89,920 shares during the quarter. Gotham Asset […]

Douglass Winthrop Advisors LLC decreased its stake in Centene Co. (NYSE:CNC – Free Report) by 3.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,042 shares of the company’s stock after selling 600 shares during the period. Douglass Winthrop Advisors LLC’s […]

While patients with other diseases have benefitted from the use of biomarkers, the lack of a biomarker in small cell lung cancer remains a disappointment, said Tom Stinchcombe, MD, medical oncologist, Duke Cancer Institute.

Sio Capital Management LLC acquired a new position in shares of Centene Co. (NYSE:CNC – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 432,834 shares of the company’s stock, valued at approximately $27,359,000. Centene makes up 13.5% of […]

A study found that negative experiences and concern for future children's health drive hemophilia carriers to choose prenatal tests, with cognitive factors playing a role.

Centene (NYSE:CNC – Get Free Report) issued an update on its FY23 earnings guidance on Wednesday morning. The company provided EPS guidance of at least $6.45 for the period, compared to the consensus EPS estimate of $6.48. Centene also updated its FY 2024 guidance to $6.60- EPS. Wall Street Analysts Forecast Growth A number of […]